CO6230983A2 - Derivados de 1 - oxo - 1, 2 - dihidro - isoqinolina, procesos para su preparacion y composiciones farmaceuticas que los contienen - Google Patents
Derivados de 1 - oxo - 1, 2 - dihidro - isoqinolina, procesos para su preparacion y composiciones farmaceuticas que los contienenInfo
- Publication number
- CO6230983A2 CO6230983A2 CO09103185A CO09103185A CO6230983A2 CO 6230983 A2 CO6230983 A2 CO 6230983A2 CO 09103185 A CO09103185 A CO 09103185A CO 09103185 A CO09103185 A CO 09103185A CO 6230983 A2 CO6230983 A2 CO 6230983A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- halo
- alkoxy
- optionally substituted
- independently selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1.- Un compuesto de fórmula (I):donde: R1 se selecciona entre H, (C1-C6)alquilo, (C2-C6)alquenilo, (C3-C6)alquinilo, (CH2)a-X-Ar y (CR101R102)a-X-Ar, donde dicho (C1-C6)alquilo está opcionalmente sustituido con 1, 2 ó 3 grupos seleccionados independientemente entre -(C1-C6)alcoxi, -halo, -OH, -heterocicloalquilo, (C3-C7)cicloalquilo y -NR8R9;R2 y R3 se seleccionan independientemente entre H, halo, (C1-C6)alquilo, (C1-C6)alcoxi y (CH2)d-Y; donde dicho (C1-C6)alquilo está opcionalmente sustituido con 1, 2 ó 3 grupos seleccionados independientemente entre -(C1-C6)alcoxi, -halo y -OH; y donde dicho (C1-C6)alcoxi está opcionalmente sustituido con 1, 2 ó 3 grupos seleccionados independientemente entre -halo y -OH; y siempre que cuando R2 sea (CH2)d-Y, R3 se seleccione entre H, halo, (C1-C6)alquilo y (C1-C6)alcoxi; y siempre que cuando R3 sea (CH2)d-Y, R2 se seleccione entre H, halo, (C1-C6)alquilo y (C1-C6)alcoxi; R4 y R5 se seleccionan independientemente entre H, (C1-C6)alquilo, (C1-C6)alcoxi, halo, CF3 y CN; R16 se seleccione entre H, (C1-C6)alquilo y heterocicloalquilo, donde dicho (C1-C6)alquilo está opcionalmente sustituido con -(C1-C6)alcoxi, -OH, -halo, -(C3-C7)cicloalquilo y -NR25R26;R17 se seleccione entre H y (C1-C6)alquilo; o R16 y R17 junto con el átomo de nitrógeno al cual están unidos forman un anillo de 3 a 7 miembros, que contiene opcionalmente otro heteroátomo seleccionado entre NR27, S y O; y que contiene opcionalmente, cuando es posible, 1 ó 2 enlaces dobles; donde dicho anillo está opcionalmente sustituido en el carbono con 1 o 2 sustituyentes seleccionados independientemente entre -(C1-C6)alquilo, (C1-C6)alcoxi, (C2-C6)alquenilo, -OH, -CN, halo y -NR25R26, donde dicho -(C1-C6)alquilo está opcionalmente sustituido con -OH. R25 y R26 se seleccionan independientemente entre H y (C1-C6)alquilo donde dicho (C1-C6)alquilo está opcionalmente sustituido con -(C1-C6)alcoxi, -OH, -halo, -(C3-C7)cicloalquilo y -NR22R23; o R25 y R26 junto con el átomo de nitrógeno al cual están unidos forman un anillo de 3 a 7 miembros, que contiene opcionalmente otro heteroátomo seleccionado entre NR24, S y O; ...
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91023507P | 2007-04-05 | 2007-04-05 | |
US97952307P | 2007-10-12 | 2007-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6230983A2 true CO6230983A2 (es) | 2010-12-20 |
Family
ID=39560895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09103185A CO6230983A2 (es) | 2007-04-05 | 2009-09-22 | Derivados de 1 - oxo - 1, 2 - dihidro - isoqinolina, procesos para su preparacion y composiciones farmaceuticas que los contienen |
Country Status (19)
Country | Link |
---|---|
US (1) | US8012979B2 (es) |
EP (1) | EP2144881B1 (es) |
JP (1) | JP5400759B2 (es) |
KR (1) | KR20100016218A (es) |
CN (1) | CN101679275B (es) |
AR (1) | AR065965A1 (es) |
AU (1) | AU2008235359B2 (es) |
BR (1) | BRPI0810047A2 (es) |
CA (1) | CA2681221A1 (es) |
CL (1) | CL2008000973A1 (es) |
CO (1) | CO6230983A2 (es) |
EC (1) | ECSP099679A (es) |
IL (1) | IL201015A0 (es) |
MX (1) | MX2009010225A (es) |
PE (1) | PE20090141A1 (es) |
RU (1) | RU2472781C2 (es) |
TW (1) | TW200845988A (es) |
UY (1) | UY31005A1 (es) |
WO (1) | WO2008122765A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR073711A1 (es) * | 2008-10-01 | 2010-11-24 | Astrazeneca Ab | Derivados de isoquinolina |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
CN103864684A (zh) * | 2012-12-07 | 2014-06-18 | 天津科技大学 | 一种新颖的3,4-二氢-1(2h)异喹啉类衍生物的合成与抗肿瘤药物的应用 |
AU2014338070A1 (en) | 2013-10-23 | 2016-05-05 | Chugai Seiyaku Kabushiki Kaisha | Quinazolinone and isoquinolinone derivative |
FR3017868A1 (fr) * | 2014-02-21 | 2015-08-28 | Servier Lab | Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN109251211A (zh) * | 2016-12-21 | 2019-01-22 | 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) | 一类喹诺酮羧酸化合物及其中间体、制备方法以及应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU176214B (en) * | 1977-05-18 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new 5,6-dihydro-imidazo-square bracket-5,1-a-square bracket closed-isoquinolin derivatives |
SK287238B6 (sk) | 1999-03-17 | 2010-04-07 | Astrazeneca Ab | Amidové deriváty, spôsob ich prípravy, farmaceutická kompozícia, ktorá ich obsahuje, a ich použitie |
CA2476162A1 (en) * | 2002-02-13 | 2003-08-21 | Takeda Chemical Industries, Ltd. | Jnk inhibitor |
US6867320B2 (en) * | 2002-02-21 | 2005-03-15 | Asahi Kasei Pharma Corporation | Substituted phenylalkanoic acid derivatives and use thereof |
CA2477208C (en) * | 2002-02-21 | 2010-11-30 | Asahi Kasei Pharma Corporation | Substituted phenylalkanoic acid derivatives and use thereof |
ATE450492T1 (de) | 2003-08-06 | 2009-12-15 | Basf Se | Verfahren zum betreiben einer kontinuierlichen heterogen katalysierten gasphasen- partialoxidation wenigstens einer organischen verbindung |
AU2004265191A1 (en) * | 2003-08-14 | 2005-02-24 | Asahi Kasei Pharma Corporation | Substituted arylalkanoic acid derivative and use thereof |
JP2007008816A (ja) | 2003-10-15 | 2007-01-18 | Ube Ind Ltd | 新規イソキノリン誘導体 |
US20070054916A1 (en) * | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
MY140868A (en) | 2004-12-24 | 2010-01-29 | Astrazeneca Ab | Amide derivatives |
TW200728277A (en) * | 2005-06-29 | 2007-08-01 | Palau Pharma Sa | Bicyclic derivatives as P38 inhibitors |
RU2440988C2 (ru) | 2005-07-26 | 2012-01-27 | Санофи-Авентис | ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛАМИНИЗОХИНОЛОНА В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ |
-
2008
- 2008-04-03 CL CL2008000973A patent/CL2008000973A1/es unknown
- 2008-04-03 TW TW097112152A patent/TW200845988A/zh unknown
- 2008-04-04 CA CA002681221A patent/CA2681221A1/en not_active Abandoned
- 2008-04-04 WO PCT/GB2008/001171 patent/WO2008122765A1/en active Application Filing
- 2008-04-04 KR KR1020097023057A patent/KR20100016218A/ko not_active Application Discontinuation
- 2008-04-04 US US12/062,718 patent/US8012979B2/en not_active Expired - Fee Related
- 2008-04-04 AU AU2008235359A patent/AU2008235359B2/en not_active Ceased
- 2008-04-04 RU RU2009136246/04A patent/RU2472781C2/ru not_active IP Right Cessation
- 2008-04-04 CN CN2008800191868A patent/CN101679275B/zh not_active Expired - Fee Related
- 2008-04-04 EP EP08718978A patent/EP2144881B1/en active Active
- 2008-04-04 UY UY31005A patent/UY31005A1/es unknown
- 2008-04-04 AR ARP080101429A patent/AR065965A1/es unknown
- 2008-04-04 PE PE2008000613A patent/PE20090141A1/es not_active Application Discontinuation
- 2008-04-04 BR BRPI0810047-0A2A patent/BRPI0810047A2/pt not_active IP Right Cessation
- 2008-04-04 JP JP2010501584A patent/JP5400759B2/ja not_active Expired - Fee Related
- 2008-04-04 MX MX2009010225A patent/MX2009010225A/es not_active Application Discontinuation
-
2009
- 2009-09-17 IL IL201015A patent/IL201015A0/en unknown
- 2009-09-22 CO CO09103185A patent/CO6230983A2/es not_active Application Discontinuation
- 2009-10-07 EC EC2009009679A patent/ECSP099679A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2681221A1 (en) | 2008-10-16 |
KR20100016218A (ko) | 2010-02-12 |
US8012979B2 (en) | 2011-09-06 |
AR065965A1 (es) | 2009-07-15 |
EP2144881A1 (en) | 2010-01-20 |
EP2144881B1 (en) | 2012-06-20 |
CN101679275A (zh) | 2010-03-24 |
RU2472781C2 (ru) | 2013-01-20 |
JP5400759B2 (ja) | 2014-01-29 |
AU2008235359B2 (en) | 2011-12-15 |
CN101679275B (zh) | 2013-07-31 |
UY31005A1 (es) | 2008-11-28 |
PE20090141A1 (es) | 2009-04-30 |
WO2008122765A1 (en) | 2008-10-16 |
RU2009136246A (ru) | 2011-05-10 |
IL201015A0 (en) | 2010-05-17 |
MX2009010225A (es) | 2009-12-14 |
TW200845988A (en) | 2008-12-01 |
ECSP099679A (es) | 2009-11-30 |
CL2008000973A1 (es) | 2009-01-02 |
JP2010523533A (ja) | 2010-07-15 |
US20090023746A1 (en) | 2009-01-22 |
BRPI0810047A2 (pt) | 2014-10-21 |
AU2008235359A1 (en) | 2008-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6230983A2 (es) | Derivados de 1 - oxo - 1, 2 - dihidro - isoqinolina, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
AR061369A1 (es) | Derivados de pirimidina y composiciones farmaceuticas que los comprenden | |
ATE353870T1 (de) | Dibenzylaminverbindung und deren medizinische verwendung | |
CO6251260A2 (es) | Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c. | |
NO20082243L (no) | Fremgangsmater og forbindelser for fremstiliing av CC-1065 analoger | |
PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
AR059895A1 (es) | Derivados biciclicos de acidos carboxilicos que resultan de utilidad para tratar trastornos metabolicos | |
AR066562A1 (es) | Derivados de pirrol condensados; una formulacion farmaceutica en base al compuesto y su uso para preparar medicamentos | |
ES2685568T3 (es) | Inhibidores de la isoquinolinona o quinazolinona fosfatidilinositol 3-quinasa | |
PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
AR076765A1 (es) | Compuestos antivirales | |
CO6140059A2 (es) | Derivados de imidazol-pirimidina para el tratamiento de enfermedades relacionadas con la glicogeno sintasa quinasa (gsk3) | |
AR057987A1 (es) | Compuestos agonistas de cb1 (receptor cannabinoide) | |
MY139750A (en) | Cyclohexylamides as dopamine d3, d2 and 5ht1a antagonists | |
TW200745061A (en) | Macrocylic inhibitors of hepatitis C virus | |
CO5601021A2 (es) | Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb | |
AR023152A1 (es) | Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion | |
AR070479A1 (es) | Derivado heterociclico fusionado y su uso | |
AR073412A1 (es) | Derivados de espiro imidazolona como antagonistas del receptor glucagon y composiciones que los comprende. | |
AR060623A1 (es) | Compuestos derivados de 2-azetidinona y un metodo de preparacion | |
WO2006123165A3 (en) | Pyrimidine derivatives as hsp90 inhibitors | |
AR109991A1 (es) | Tratamientos de combinación que comprenden la administración de imidazopirazinonas | |
CO5590960A2 (es) | Derivados de azaindolilalquilamina como ligandos de 5- hidroxitriptamina-6 | |
AR109990A1 (es) | Derivados de imidazopirazinonas inhibidores de pde1 | |
AR110282A1 (es) | Compuestos de amida bicíclica y uso de éstos en el tratamiento de enfermedades mediadas por rip1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |